Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Arik Drucker, Byong Hoon Yoo, Iman Aftab Khan, Dongsic Choi, Laura Montermini, Xiaoyang Liu, Sanja Jovanovic, Tallal Younis, Kirill V. Rosen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Breast Cancer Research |
Online Access: | http://link.springer.com/article/10.1186/s13058-020-01358-8 |
Similar Items
-
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
by: Arik Durcker, et al.
Published: (2020-10-01) -
erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy
by: Karim S. ElSahwi, et al.
Published: (2011-01-01) -
Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance
by: Tameka A Bailey, et al.
Published: (2011-01-01) -
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab
by: Juliana Bentes Hughes, et al.
Published: (2012-06-01) -
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
by: Alwin Jeyakumar, et al.
Published: (2012-01-01)